Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky
Masters of Scale
Intro
This chapter explores the difficulties faced by a new pharmaceutical initiative striving to transform drug pricing and enhance accessibility. It details the competitive barriers set by established companies and includes a pivotal meeting with a key industry figure that highlights the complexities of entrepreneurial collaboration.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
